Advances in therapeutic treatment options for ANCA-associated vasculitis

Shealynn Carpenter, Jan Willem Cohen Tervaert*, Elaine Yacyshyn

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)127-136
Number of pages10
JournalExpert Opinion on Orphan Drugs
Volume8
Issue number4
DOIs
Publication statusPublished - 2 Apr 2020

Keywords

  • ANCA-associated vasculitis
  • drug therapy
  • remission induction
  • maintenance therapy
  • ANTIBODY-ASSOCIATED VASCULITIS
  • AZATHIOPRINE MAINTENANCE THERAPY
  • DAILY ORAL CYCLOPHOSPHAMIDE
  • TERM-FOLLOW-UP
  • REMISSION INDUCTION
  • RANDOMIZED-TRIAL
  • PLASMA-EXCHANGE
  • EOSINOPHILIC GRANULOMATOSIS
  • MYCOPHENOLATE-MOFETIL
  • CLINICAL-OUTCOMES

Cite this